1. Home
  2. BLMN vs YDES Comparison

BLMN vs YDES Comparison

Compare BLMN & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bloomin' Brands Inc.

BLMN

Bloomin' Brands Inc.

HOLD

Current Price

$7.87

Market Cap

674.3M

ML Signal

HOLD

YDES

YD Bio Limited Ordinary Shares

HOLD

Current Price

$6.91

Market Cap

543.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLMN
YDES
Founded
1988
2013
Country
United States
Taiwan
Employees
N/A
N/A
Industry
Restaurants
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
674.3M
543.0M
IPO Year
2012
2024

Fundamental Metrics

Financial Performance
Metric
BLMN
YDES
Price
$7.87
$6.91
Analyst Decision
Hold
Analyst Count
8
0
Target Price
★ $7.88
N/A
AVG Volume (30 Days)
★ 1.9M
701.4K
Earning Date
05-06-2026
05-12-2026
Dividend Yield
★ 4.99%
N/A
EPS Growth
★ 106.71
N/A
EPS
★ 1.01
N/A
Revenue
★ $4,213,346,000.00
N/A
Revenue This Year
$2.07
N/A
Revenue Next Year
$1.81
N/A
P/E Ratio
$7.80
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.19
$1.70
52 Week High
$12.63
$22.00

Technical Indicators

Market Signals
Indicator
BLMN
YDES
Relative Strength Index (RSI) 33.99 74.07
Support Level $7.79 $1.99
Resistance Level $8.74 $9.11
Average True Range (ATR) 0.44 0.82
MACD -0.07 0.26
Stochastic Oscillator 10.35 95.52

Price Performance

Historical Comparison
BLMN
YDES

About BLMN Bloomin' Brands Inc.

Bloomin Brands Inc is a casual dining restaurant company, with a portfolio of, differentiated restaurant concepts. Its restaurant portfolio includes Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill and Fleming's Prime Steakhouse & Wine Bar. Its restaurant concepts range in price point and degree of formality from casual (Outback Steakhouse and Carrabba's Italian Grill) to polished casual (Bonefish Grill) and fine dining (Fleming's Prime Steakhouse & Wine Bar). The U.S. segment includes all restaurants operating in the U.S. while franchised restaurants operating outside the U.S. are included in the international franchise segment.

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

Share on Social Networks: